← All diseases
Cancer
Acute myeloid leukemia
Would you like to receive a message when there is new research on Acute myeloid leukemia? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you will be notified as soon as new research on Acute myeloid leukemia is available. View what Premium costs.
Publications and studies (2129)
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Isolated Myeloid Sarcoma of the Thoracic Spine as Initial Presentation of Acute Promyelocytic Leukemia: A Case Report and Literature Review. (2026/08/03) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acute erythroid leukaemia transformation in polycythaemia vera with leukemic involvement in liver and ascites. (2026/08/03) ♡
- Endoplasmic reticulum stress promotes leukemic plasmacytoid dendritic cell differentiation skewing and immune suppression in acute myeloid leukemia. (2026/08/03) ♡
- Venetoclax-Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE): Implications for Diagnosis and Treatment Continuation. (2026/08/03) ♡
- Central Nervous System Immune Reconstitution Inflammatory Syndrome During Neutrophil Recovery in Pediatric Acute Myeloid Leukemia: A Clinical and Laboratory Observation. (2026/08/03) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Oral Leukemic Infiltrates: A Case Report. (2026/08/03) ♡
- Real-world safety and effectiveness of olaparib maintenance after first-relapse platinum-sensitive ovarian cancer in Japan: a multicenter historical cohort (JGOG3026). (2026/08/03) ♡
- Polarised dysplastic basophils in a TP53-mutated acute myeloid leukaemia. (2026/08/02) ♡
- AI-Based Computational Model Integrating Routinely Acquired Blood Parameters for Triage and Early Detection of Acute Myeloid Leukemia. (2026/08/02) ♡
- Targeting oncogenic FLT3 uncovers a ferroptosis vulnerability through selenocysteine recoding in acute myeloid leukaemia. (2026/08/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Acute and Chronic Leukemia in Sub-Saharan Africa: A Systematic Review. (2026/08/01) ♡
- Co-overexpression of CDC27 and PD-L1 defines an ultra-high-risk subgroup of acute myeloid leukemia in an Egyptian cohort. (2026/08/01) ♡
- Sodium Overload-Related Molecular Subtypes and a Four-Gene Prognostic Signature Predict Survival, Immune Landscape, and Therapeutic Response in Acute Myeloid Leukemia. (2026/08/01) ♡
- Association between venetoclax concentration and febrile neutropenia in acute leukemia: a retrospective analysis. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The eco-evolutionary dynamics of acute myeloid leukemia: From clonal games to clinical intervention. (2026/08/01) ♡
- Improvement in Outcomes of Childhood Acute Myeloid Leukemia Treatment: A Survival Analysis at a Reference University Hospital in Rio de Janeiro, Brazil. (2026/08/01) ♡
- Identification and Validation of Metabolic Hub Genes Using WGCNA and Prognostic Risk Modeling in Acute Myeloid Leukemia. (2026/08/01) ♡
- Complex Genomic Alterations in TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia Involving EPOR/JAK2 Amplification, ERG Copy Gains, and TCF3 Deletion. (2026/08/01) ♡
- Antifungal Management in Patients with Hematologic Malignancies: From Primary Prophylaxis to Empirical and Diagnostic-Driven Treatment. (2026/07/31) ♡
- High-throughput UHPLC-MS/MS Assay for the Quantification of Venetoclax in Patients with Acute Myeloid Leukemia and Assessment of Clinical Application: A Short Communication. (2026/07/31) ♡
- Targeting ACSF2 overcomes Ara-C resistance in acute myeloid leukemia via the cholesterol metabolism-ERK signaling axis. (2026/07/31) ♡
- ZMAT3 alleviates cell death in Fanconi anemia via adaptation of sphingolipid metabolism. (2026/07/31) ♡
- Dose-Adjusted Treatment With 7-Day Venetoclax Plus Azacitidine or Decitabine in Patients With Acute Myeloid Leukaemia. (2026/07/30) ♡
- Chromatin Accessibility Shapes Developmental-Specific Lineage Plasticity in Hematopoiesis. (2026/07/30) ♡
- PROTAC-mediated targeting of IKKβ and NR4A1 for AML therapy. (2026/07/30) ♡
- Late acquisition of BCR::ABL1 during clonal evolution of SAMD9-associated MDS with phenotypic shift from AML to B-ALL. (2026/07/30) ♡
- Fragment mapping-guided virtual screening identifies a small-molecule modulator of NPM1 oligomerization. (2026/07/30) ♡
- Paris saponin VII promotes TRIP12-mediated SOD1 degradation to synergize with idarubicin in ROS-dependent acute myeloid leukemia cell death. (2026/07/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer. (2026/07/27) ♡
- scOPE identifies which driver-associated expression programs transfer from bulk tumors to single cells. (2026/07/26) ♡
- Patient and caregiver knowledge and understanding of acute myeloid leukemia and perceptions of oncologist communication quality. (2026/07/25) ♡
- Severe Folate Deficiency Mimicking Myelodysplastic Syndrome/Acute Myeloid Leukemia: A Case Report. (2026/07/24) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Acute monocytic leukemia mimicking large-vessel vasculitis on (18)F-FDG PET/CT. (2026/07/23) ♡
- Clinical characteristics and risk factors of acute cutaneous graft-vs.-host disease following allogeneic hematopoietic stem cell transplantation in pediatric acute myeloid leukemia: a single-center retrospective study. (2026/07/23) ♡
- Ribonucleotide Reductase Inhibition Overcomes FLT3 Inhibitor Resistance in Acute Myeloid Leukemia. (2026/07/22) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acute lymphoblastic leukemia presenting as myocardial infiltration mimicking hypertrophic cardiomyopathy: a case report. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Functional heterogeneity of TP53 mutants in venetoclax-resistant AML: mechanisms, clinical implications, and therapeutic opportunities. (2026/07/22) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Early T-cell precursor acute lymphoblastic leukemia with aberrant CD19 expression and an NPM1 mutation. (2026/07/22) ♡
- Febrile neutropenia in children and adolescents with acute myeloid leukemia during induction therapy. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hypomethylating agents are the current therapy backbone for MDS and AML relapsing after allogeneic hematopoietic stem cell transplantation. (2026/07/22) ♡
- Macrophage NPM1 drives anti-tumor immunity via the STAT3-CCRL2 axis. (2026/07/22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Multicenter Flow Cytometry For Acute Myeloid Leukemia Measurable Residual Disease With LAIP/DfN And CD34+CD38- Leukemic Stem Cell-Enriched Populations. (2026/07/21) ♡
- Unifying multimodal single-cell data with a mixture-of-experts β -variational autoencoder framework. (2026/07/21) ♡
- Outcomes of infantile leukemia in a Saudi multicenter cohort: patterns of treatment response, treatment failure, relapse, and survival. (2026/07/20) ♡
- Pre-transplant measurable residual disease by flow cytometry is an independent prognostic factor in pediatric acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation. (2026/07/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. NAD Metabolism in Acute Myeloid Leukaemia: Biological Rationale and Therapeutic Opportunities. (2026/07/13) ♡
- Specific F(1) ATP synthase inhibition delivers transient mitochondrial stress for selective targeting of acute myeloid leukemia. (2026/07/13) ♡
- Intracellular iron homeostasis-regulated epigenetic reprogramming contributes to -7/del(7q) leukemia. (2026/07/10) ♡
- Pre- and post-transplant serum albumin levels and outcomes after allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia. (2026/07/06) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. An Interesting Case of T/Myeloid Mixed Phenotypic Acute Leukemia with Bilineal/Biphenotypic Features and a Novel WT1 Mutation. (2026/07/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.